NO953406L - Pyrrolo-pyridinderivater - Google Patents

Pyrrolo-pyridinderivater

Info

Publication number
NO953406L
NO953406L NO953406A NO953406A NO953406L NO 953406 L NO953406 L NO 953406L NO 953406 A NO953406 A NO 953406A NO 953406 A NO953406 A NO 953406A NO 953406 L NO953406 L NO 953406L
Authority
NO
Norway
Prior art keywords
pyrrolo
pyridine derivatives
dopamine
receptor subtypes
substituted
Prior art date
Application number
NO953406A
Other languages
English (en)
Other versions
NO953406D0 (no
Inventor
Raymond Baker
Neil Roy Curtis
Janusz Jozef Kulagowski
Paul David Leeson
Mark Peter Ridgill
Adrian Leonard Smith
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939304111A external-priority patent/GB9304111D0/en
Priority claimed from GB939316275A external-priority patent/GB9316275D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO953406D0 publication Critical patent/NO953406D0/no
Publication of NO953406L publication Critical patent/NO953406L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Abstract

En klasse av pyrrolo[2,3-b]- pyridinderivater, substituert ved 3- stillingen ved en substituert piper- azinylmethylgruppe, er antagonister av dopaminreseptorsubtyper innen hjernen, en selektiv affinitet for dopamin D.-reseptorsubtypen over andre doparain-reseptorsubtyper, og er følgelig fordelaktige ved behandling og/eller forhindring av psykotiske sykdommer slik som schizofreni, mens de utviser færre bieffekter enn de som er assosiert med klassiske neuroleptiske legemidler.
NO953406A 1993-03-01 1995-08-30 Pyrrolo-pyridinderivater NO953406L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939304111A GB9304111D0 (en) 1993-03-01 1993-03-01 Therapeutic agents
GB939316275A GB9316275D0 (en) 1993-08-05 1993-08-05 Therapeutic agents
PCT/GB1994/000337 WO1994020497A1 (en) 1993-03-01 1994-02-21 Pyrrolo-pyridine derivatives

Publications (2)

Publication Number Publication Date
NO953406D0 NO953406D0 (no) 1995-08-30
NO953406L true NO953406L (no) 1995-10-31

Family

ID=26302519

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953406A NO953406L (no) 1993-03-01 1995-08-30 Pyrrolo-pyridinderivater

Country Status (20)

Country Link
US (1) US5432177A (no)
EP (1) EP0623618A3 (no)
JP (1) JP2710751B2 (no)
KR (1) KR960701052A (no)
CN (1) CN1118598A (no)
AU (1) AU674373B2 (no)
BG (1) BG99885A (no)
BR (1) BR9406128A (no)
CA (1) CA2116213A1 (no)
CZ (1) CZ224195A3 (no)
FI (1) FI954088A0 (no)
HU (1) HUT71799A (no)
IL (1) IL108729A0 (no)
NO (1) NO953406L (no)
NZ (1) NZ261593A (no)
PL (1) PL310443A1 (no)
SI (1) SI9400091A (no)
SK (1) SK106395A3 (no)
WO (1) WO1994020497A1 (no)
YU (1) YU9194A (no)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184008T1 (de) * 1993-03-01 1999-09-15 Merck Sharp & Dohme Pyrrolopyridinderivate als dopaminrezeptor liganden
US5622950A (en) * 1993-03-01 1997-04-22 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
GB9305644D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9305641D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9305623D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9306578D0 (en) * 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
US5817679A (en) 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
US6060473A (en) * 1993-04-01 2000-05-09 Ucb S.A. - Dtb 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
AU6435594A (en) * 1993-04-15 1994-11-08 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
EP0717623A1 (en) 1993-09-10 1996-06-26 Cytomed, Inc. Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US6117889A (en) * 1994-04-01 2000-09-12 University Of Virginia 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
EP0759918A1 (en) * 1994-05-19 1997-03-05 MERCK SHARP & DOHME LTD. Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
CN1068327C (zh) * 1994-09-30 2001-07-11 辉瑞大药厂 2,7－取代的八氢－1H－吡啶并[1,2－a]吡嗪衍生物
GB9423460D0 (en) * 1994-11-21 1995-01-11 Merck Sharp & Dohme Therapeutic agents
AU4859596A (en) * 1995-02-15 1996-09-04 Pharmacia & Upjohn Company Imidazo{1,2-a}pyridines for the treatment of cns and cardiac diseases
GB2298199A (en) * 1995-02-21 1996-08-28 Merck Sharp & Dohme Synthesis of azaindoles
GB9507291D0 (en) * 1995-04-07 1995-05-31 Merck Sharp & Dohme Therapeutic agents
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
US5725838A (en) * 1996-05-31 1998-03-10 Resolution Pharmaceuticals, Inc. Radiolabeled D4 receptor ligands
DE19637237A1 (de) * 1996-09-13 1998-03-19 Merck Patent Gmbh Piperazin-Derivate
US5976497A (en) * 1997-08-04 1999-11-02 Resolution Pharmaceuticals, Inc. Dopamine D4 receptor ligands
WO1999000386A1 (en) * 1997-06-27 1999-01-07 Resolution Pharmaceuticals Inc. Dopamine d4 receptor ligands
US6013654A (en) * 1997-08-14 2000-01-11 Pharmacia & Upjohn Company Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases
DE60011269T2 (de) * 1999-08-12 2005-06-23 Nps Allelix Corp., Mississauga Azaidole mit serotonin rezeptor affinität
US6686374B1 (en) 1999-08-12 2004-02-03 Nps Allelix Corp. Azaindoles having serotonin receptor affinity
AR028945A1 (es) * 2000-06-19 2003-05-28 Lundbeck & Co As H Derivados de indol
WO2002000645A1 (en) * 2000-06-29 2002-01-03 H. Lundbeck A/S Indole derivatives useful for the treatment of cns disorders
JP4180365B2 (ja) 2000-07-31 2008-11-12 エフ．ホフマン−ラ ロシュ アーゲー ピペラジン誘導体
US7432304B2 (en) 2001-05-30 2008-10-07 The Regents Of The University Of Michigan Small molecule antagonists of Bcl-2 family proteins
WO2002100350A2 (en) * 2001-06-13 2002-12-19 The Regents Of University Of Michigan Dopamine receptor ligands and therapeutic methods based thereon
AU2002360335A1 (en) 2001-11-01 2003-05-12 The Regents Of The University Of Michigan Small molecule inhibitors targeted at bcl-2
CN100347171C (zh) * 2002-02-08 2007-11-07 中国科学院上海原子核研究所 一种吡啶类化合物及其制备方法和作为多巴胺d4受体拮抗剂的应用
CN1305873C (zh) * 2002-07-12 2007-03-21 中国科学院上海原子核研究所 [18f]氟标记的吡啶类化合物及其制备方法和作为多巴胺d4受体显像剂的应用
JP2004123562A (ja) * 2002-09-30 2004-04-22 Japan Science & Technology Corp 神経細胞死抑制作用を有する化合物を用いた医薬
GB0314967D0 (en) * 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
CA2550361C (en) * 2003-12-19 2014-04-29 Prabha Ibrahim Compounds and methods for development of ret modulators
US20070066641A1 (en) * 2003-12-19 2007-03-22 Prabha Ibrahim Compounds and methods for development of RET modulators
JP2007530568A (ja) 2004-03-25 2007-11-01 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ゴシポール共結晶およびその使用
AU2005265017A1 (en) * 2004-06-17 2006-01-26 Plexxikon, Inc. Azaindoles modulating c-kit activity and uses therefor
US7498342B2 (en) * 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
DE102004054634A1 (de) * 2004-11-12 2006-05-18 Schwarz Pharma Ag Azaindolcarboxamide
JP2008545652A (ja) * 2005-05-17 2008-12-18 プレキシコン，インコーポレーテッド ｃ−ｋｉｔおよびｃ−ｆｍｓ活性を調節する化合物およびその用途
NZ565255A (en) * 2005-06-22 2010-04-30 Plexxikon Inc Pyrrolo[2,3-b] pyridine derivatives as protein kinase inhibitors
US7544685B2 (en) 2005-08-17 2009-06-09 H. Lundbeck A/S 2,3-dihydroindole compounds
US7696229B2 (en) 2006-02-17 2010-04-13 Memory Pharmaceuticals Corporation Compounds having 5-HT6 receptor affinity
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
WO2008079909A1 (en) * 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
US7872018B2 (en) 2006-12-21 2011-01-18 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
PE20081581A1 (es) * 2006-12-21 2008-11-12 Plexxikon Inc COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP2414356B1 (en) 2009-04-03 2015-09-02 F.Hoffmann-La Roche Ag Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
US8518933B2 (en) 2009-04-23 2013-08-27 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8546377B2 (en) * 2009-04-23 2013-10-01 Abbvie Inc. Modulators of 5-HT receptors and methods of use thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
MX2012005284A (es) 2009-11-06 2012-06-28 Plexxikon Inc Compuestos y metodos para la modulacion de cinasas. e indicaciones para ello.
EA021781B1 (ru) * 2010-12-02 2015-08-31 Эли Лилли Энд Компани 3-замещенные 6-(пиридинилметокси)пирролопиридиновые соединения
AU2012214762B2 (en) 2011-02-07 2015-08-13 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
EP2917219B1 (en) * 2012-11-08 2017-09-27 Pfizer Inc Heteroaromatic compounds and their use as dopamine d1 ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362956A (en) * 1965-08-19 1968-01-09 Sterling Drug Inc 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
US3511841A (en) * 1967-05-29 1970-05-12 Sterling Drug Inc 1-((4-,5-,6-,and 7-azaindolyl)-lower-alkyl)- 4-substituted-piperazines
US5422265A (en) * 1990-12-07 1995-06-06 State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The Oregon Health Sciences University DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells

Also Published As

Publication number Publication date
KR960701052A (ko) 1996-02-24
WO1994020497A1 (en) 1994-09-15
US5432177A (en) 1995-07-11
BG99885A (en) 1996-02-29
FI954088A (fi) 1995-08-31
BR9406128A (pt) 1996-02-27
JPH06279442A (ja) 1994-10-04
CZ224195A3 (en) 1996-03-13
CA2116213A1 (en) 1994-09-02
SI9400091A (en) 1994-12-31
AU674373B2 (en) 1996-12-19
YU9194A (sh) 1997-08-22
AU5647094A (en) 1994-09-08
SK106395A3 (en) 1995-12-06
NO953406D0 (no) 1995-08-30
CN1118598A (zh) 1996-03-13
NZ261593A (en) 1996-09-25
EP0623618A3 (en) 1997-04-02
PL310443A1 (en) 1995-12-11
HUT71799A (en) 1996-02-28
HU9501871D0 (en) 1995-08-28
IL108729A0 (en) 1994-05-30
JP2710751B2 (ja) 1998-02-10
EP0623618A2 (en) 1994-11-09
FI954088A0 (fi) 1995-08-31

Similar Documents

Publication Publication Date Title
NO953406L (no) Pyrrolo-pyridinderivater
ATE160774T1 (de) Antipsychotische benzimidazolderivate
US5151423B1 (en) Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use
SG44597A1 (en) Benzo[5,6]cycloheptapyridines composition and methods of use
ATE160779T1 (de) Antipsychotische indazolderivate
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
LTIP491A (en) Hydroxyquinolone derivatives
ATE283859T1 (de) Spiro (1-azabicyclo(2.2.2)octan-3,2'(3'h)-furo(2, 3-b)pyridin zur verwendung in der behandlung von psychotischen und intellektuellen störungen
CY2123B1 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides drugs containing these compounds and use of such drugs
FR2634799B1 (fr) Composition aqueuse pour l'assouplissement de textiles, et procede utilisant cette composition
GR3019782T3 (en) Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
ITMI930699A1 (it) Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
WO1992007832A3 (en) Substituted piperazines as central nervous system agents
BG106509A (en) Preparative form
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
EP0260642A3 (en) Thiazolo [f]-fused hexahydroquinoline derivatives as dopaminergic agents
HUT59094A (en) Process for producing 6-substituted tetrahydro-benzo(c,d)-indol derivatives and pharmaceutical compositions containing them as active components
DK480979A (da) Fremgangsmaade til fremstilling af 9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thiophen-4,9-iminer
FI971854A (fi) Substituoituja tetrasyklisiä atsepiinijohdannaisia, joilla on 5-HT2-reseptoriaffiniteetti
IE801576L (en) Pryidoindole derivatives
NO981502D0 (no) 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo£3,4':4,5|furo(3,2-b)pyridin-6,8£7H|-dionderivater for bekjempelse av endoparasitter og fremgangsmåte for fremstilling av nevnte derivater
IS3938A (is) Aðferð við framleiðslu nýrra pyrimídó [1',6':1,2]pyridó [3,4-b] indól afleiða og lyfjablandna sem innihalda þær
PT73145B (en) Process for the preparation of 7,8,9,10-tetrahydrofuro<3,2-e>pyrido<4,3-b>indole derivatives having effect on the central nervous system and their application in the preparation of pharmaceutical compositions having effect on the central nervous system
NO177786B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrido-[2,3-bÅ-benzazepin- (og -tiazepin)-5(6H)-on-derivater